OraLiva
PrivateLast Round
Seed
Oct 6, 2025
Total Funding Raised
$5.94M
Company Overview
OraLiva is a diagnostic equipment company that has developed an AI-powered cytology platform for the early detection of oral cancer.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Home & Lifestyle
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OraLiva Comparables
Compare OraLiva with similar companies based on industry and business-model similarity.
OraLiva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 6, 2025 | ||||
| Grant | Aug 15, 2025 | ||||
| Grant | Jul 10, 2025 |
OraLiva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| RTP Angel Fund | Seed |
| New York University | Seed |
| National Institute of Dental and Craniofacial Research | Grant |
| NYU Innovation Venture Fund | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
Secured $2M from National Institute of Dental and Craniofacial Research and NIH RADx.
OraLiva Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OraLiva's valuation, stock price, and market status.